CONTROVERSY .2. BIOEQUIVALENCE AS AN INDICATOR OF THERAPEUTIC EQUIVALENCE - MODELING THE THEORETIC INFLUENCE OF BIOINEQUIVALENCE ON SINGLE-DOSE DRUG EFFECT

被引：3

作者：

OLSON, SC ^{[1
]}

ELDON, MA ^{[1
]}

TOOTHAKER, RD ^{[1
]}

FERRY, JJ ^{[1
]}

COLBURN, WA ^{[1
]}

机构：

[1] WARNER LAMBERT PARKE DAVIS, PHARMACEUT RES, ANN ARBOR, MI 48105 USA

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 1987年 / 27卷 / 05期

关键词：

D O I：

10.1002/j.1552-4604.1987.tb03029.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：342 / 345

页数：4

相关论文

共 19 条

[1] ALBERT KS, 1980, DRUG ABSORPTION DISP
[2] SIMULTANEOUS PHARMACOKINETIC AND PHARMACODYNAMIC MODELING
COLBURN, WA
[J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (03): : 367 - 388
[3] DANIELSON DA, 1985, GENERICS, V1, P21
[4] A TIME TO SPEAK OUT ON BIOEQUIVALENCE AND THERAPEUTIC EQUIVALENCE
DETTELBACH, HR
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 26 (05) : 307 - 308
[5] DICKINSON J, 1986, PHARM TECHNOL, V10, P22
[6] GOTTSCHALK LA, 1986, J CLIN PSYCHIAT, V47, P3
[7] UNDERSTANDING THE DOSE-EFFECT RELATIONSHIP - CLINICAL-APPLICATION OF PHARMACOKINETIC-PHARMACODYNAMIC MODELS
HOLFORD, NHG
SHEINER, LB
[J]. CLINICAL PHARMACOKINETICS, 1981, 6 (06) : 429 - 453
[8] MODELING THE PHARMACOKINETICS AND PHARMACODYNAMICS OF TRIMAZOSIN
KELMAN, AW
MEREDITH, PA
ELLIOTT, HL
REID, JL
[J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 1986, 7 (04) : 373 - 388
[9] GENERIC EQUIVALENTS - ISSUES AND CONCERNS
LAMY, PP
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 26 (05) : 309 - 316
[10] BIOAVAILABILITY, CLINICAL EFFECTIVENESS, AND PUBLIC INTEREST
LEVY, G
[J]. PHARMACOLOGY, 1972, 8 (1-3) : 33 - 43